Literature DB >> 2760755

Substance abuse prognosis with an additional psychiatric diagnosis: understanding the relationship.

B E Stoffelmayr1, L A Benishek, K Humphreys, J A Lee, B E Mavis.   

Abstract

Patients with alcohol and other substance abuse problems have poorer prognoses if there is a concomitant psychiatric diagnosis. However, because severity of psychiatric problems contributes more than the specific psychiatric diagnosis to prognosis, the nature of the interaction between substance abuse treatment outcome and an accompanying psychiatric diagnosis can be questioned. In this article an attempt is made to understand the poor-prognosis-with-psychiatric-diagnosis interaction through a literature review and an analysis of various problem areas that clients bring to substance abuse treatment. Problem areas were measured with a variety of instruments. The results show that groups that vary in severity of psychiatric problems also differ in severity of problems in other areas. As there is no doubt that such dual diagnosis patients pose a considerable treatment challenge, the implications of these findings for theoretical consideration and treatment planning are discussed.

Entities:  

Mesh:

Year:  1989        PMID: 2760755     DOI: 10.1080/02791072.1989.10472154

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  7 in total

1.  Correlates of functioning in a population with dual diagnoses: an examination of diagnosis and problem history.

Authors:  L C Jordan; D A Luke; C T Mowbray; S E Herman; W S Davidson; C Conklin
Journal:  J Ment Health Adm       Date:  1996

2.  Representativeness of patients enrolled in influential clinical trials: a comparison of substance dependence with other medical disorders.

Authors:  Keith Humphreys; Natalya C Maisel; Janet C Blodgett; John W Finney
Journal:  J Stud Alcohol Drugs       Date:  2013-11       Impact factor: 2.582

Review 3.  Policy-relevant program evaluation in a national substance abuse treatment system.

Authors:  K Humphreys; E G Hamilton; R H Moos; R T Suchinsky
Journal:  J Ment Health Adm       Date:  1997

Review 4.  Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.

Authors:  Keith Humphreys; Chelsea L Shover; Christina M Andrews; Amy S B Bohnert; Margaret L Brandeau; Jonathan P Caulkins; Jonathan H Chen; Mariano-Florentino Cuéllar; Yasmin L Hurd; David N Juurlink; Howard K Koh; Erin E Krebs; Anna Lembke; Sean C Mackey; Lisa Larrimore Ouellette; Brian Suffoletto; Christine Timko
Journal:  Lancet       Date:  2022-02-02       Impact factor: 202.731

5.  Long-Term Outcomes of First-Admission Psychosis: A Naturalistic 21-Year Follow-Up Study of Symptomatic, Functional and Personal Recovery and Their Baseline Predictors.

Authors:  Victor Peralta; Elena García de Jalón; Lucía Moreno-Izco; David Peralta; Lucía Janda; Ana M Sánchez-Torres; Manuel J Cuesta
Journal:  Schizophr Bull       Date:  2022-05-07       Impact factor: 7.348

6.  The interaction of co-occurring mental disorders and recovery management checkups on substance abuse treatment participation and recovery.

Authors:  Brian R Rush; Michael L Dennis; Christy K Scott; Saulo Castel; Rodney R Funk
Journal:  Eval Rev       Date:  2008-02

7.  The relationship of Medicaid expansion to psychiatric comorbidity care within substance use disorder treatment programs.

Authors:  Chelsea L Shover; Amanda Abraham; Thomas D'Aunno; Peter D Friedmann; Keith Humphreys
Journal:  J Subst Abuse Treat       Date:  2019-07-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.